Patent · US Expired

Method of treatment and agents useful for same

US7455836B2 · kind B2 · utility

29Cited by
9References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 8, 2001
Grant dateNov 25, 2008
Priority date
Expiry dateDec 23, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to a method for the treatment and prophylaxis of inflammatory conditions. The present invention is predicated in part on the identification of cells of the monocyte/macrophage lineage being critical for inflammation and, in particular, chronic inflammation. In accordance with the present invention, it is proposed that the reduction in levels of monocyte/macrophage-type cells and/or a reduction in the production of inflammatory and pro-inflammatory mediators by these cells, especially locally, is effective in reducing inflammatory conditions. The present invention further provides animal models useful for screening for reducing levels of monocyte/macrophage-type cells and/or reducing the production of inflammatory and pro-inflammatory mediators of these cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.